Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Market Cap

Madrigal Pharmaceuticals has a market cap or net worth of $12.61 billion as of July 29, 2026. Its market cap has increased by 93.05% in one year.

• Market Cap: 12.61B
• Enterprise Value: 12.14B
• 1-Year Change: 93.05%
• Ranking: #832
• Category: Large-Cap
• Stock Price: $546.88

Market Cap Chart

Chart

Since February 6, 2007, Madrigal Pharmaceuticals's market cap has increased from $297.50M to $12.61B, an increase of 4,138.21%. That is a compound annual growth rate of 21.20%.

Market Cap History

Date	Market Cap	% Change
Jul 29, 2026	12.61B	-4.67%
Dec 31, 2025	13.23B	96.52%
Dec 31, 2024	6.73B	47.33%
Dec 29, 2023	4.57B	-7.98%
Dec 30, 2022	4.96B	242.65%
Dec 31, 2021	1.45B	-15.74%
Dec 31, 2020	1.72B	22.31%
Dec 31, 2019	1.41B	-18.98%
Dec 31, 2018	1.74B	51.27%
Dec 29, 2017	1.15B	565.31%
Dec 30, 2016	172.40M	255.46%
Dec 31, 2015	48.50M	-83.19%
Dec 31, 2014	288.60M	-20.30%
Dec 31, 2013	362.10M	-35.14%
Dec 31, 2012	558.30M	141.48%
Dec 30, 2011	231.20M	-6.85%
Dec 31, 2010	248.20M	44.39%
Dec 31, 2009	171.90M	-17.20%
Dec 31, 2008	207.60M	-8.55%
Dec 31, 2007	227.00M	-23.70%
Feb 6, 2007	297.50M	-

View and export this data all the way back to 2007. Sign Up Today.

Data Source: Nasdaq Data Link Last updated: Jul 29, 2026

Market cap data is provided by Nasdaq Data Link. The current market cap updates continuously throughout the trading day, while the historical market cap is updated daily after market close.

Update frequency:

Daily

Last checked:

Jul 30, 2026

Data Sources Report a data error

Related Stocks

Company	Market Cap
Exelixis	13.91B
Arrowhead Pharmaceuticals	12.14B
BioMarin Pharmaceutical	11.86B
Axsome Therapeutics	11.70B
Bio-Techne	11.22B
Krystal Biotech	10.71B
Cytokinetics	10.64B
ABIVAX Société Anonyme	10.63B